Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Selenoesters and selenoanhydrides as novel multidrug resistance reversing agents: A confirmation study in a colon cancer MDR cell line

Published:2017-02 Issue:4 Volume:27 Page:797-802
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Gajdács Márió,Spengler Gabriella,Sanmartín Carmen,Marć Małgorzata Anna,Handzlik Jadwiga,Domínguez-Álvarez Enrique

Funder

Szeged Foundation for Cancer Research

European Union

State of Hungary

European Social Fund

Hungarian Academy of Sciences

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference43 articles.

1. Selenium Compounds, Apoptosis and Other Types of Cell Death: An Overview for Cancer Therapy

2. Selenium compounds as therapeutic agents in cancer

3. Selenium and human health

4. Selenite-mediated production of superoxide radical anions in A549 cancer cells is accompanied by a selective increase in SOD1 concentration, enhanced apoptosis and Se–Cu bonding

5. Aspects of a Distinct Cytotoxicity of Selenium Salts and Organic Selenides in Living Cells with Possible Implications for Drug Design

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Short Communication: Novel Di- and Triselenoesters as Effective Therapeutic Agents Inhibiting Multidrug Resistance Proteins in Breast Cancer Cells;International Journal of Molecular Sciences;2024-09-08

2. Fast Intramolecular Thiol-Activated Arylselenoamides Provide Access to Triggered, Fluorogenic H₂Se Donors;Journal of the American Chemical Society;2024-08-26

3. An Examination of Chemical Tools for Hydrogen Selenide Donation and Detection;Molecules;2024-08-15

4. Di- and Triselenoesters—Promising Drug Candidates for the Future Therapy of Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2024-07-16

5. Selenization of Small Molecule Drugs: A New Player on the Board;Journal of Medicinal Chemistry;2024-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3